Quality of drug prescribing in older patients: Is there a problem and can we improve it?

Internal Medicine Journal

Volumn 40, Issue 1, 2010, Pages 7-18

  Scott, I ^a   Jayathissa, S ^b  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Hutt Valley Health ^*  (New Zealand)

Author keywords

Drug prescribing; Older patients; Quality

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; AMITRIPTYLINE; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CARDIAC GLYCOSIDE; CARDIOVASCULAR AGENT; CIMETIDINE; CLONIDINE; DIAZEPAM; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENHYDRAMINE; DOSULEPIN; HYPNOTIC SEDATIVE AGENT; KETOROLAC; LOOP DIURETIC AGENT; METHYLDOPA; NEUROLEPTIC AGENT; NIFEDIPINE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; STEROID; UNINDEXED DRUG;

ADVERSE DRUG REACTION; AGED; ANGINA PECTORIS; ANKLE EDEMA; ANTICHOLINERGIC EFFECT; AUSTRALIA; BRADYCARDIA; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC LUNG DISEASE; CONFUSION; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG MISUSE; DRUG SCREENING; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTENSION; KIDNEY FAILURE; LIVER DISEASE; MEDICAL PRACTICE; MORTALITY; NEOPLASM; NEW ZEALAND; PHARMACIST; PHYSICIAN; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SYSTOLIC HEART FAILURE; TORSADE DES POINTES; TOTAL QUALITY MANAGEMENT; URINARY EXCRETION;

AGE FACTORS; AGED; DRUG PRESCRIPTIONS; DRUG TOXICITY; HOSPITALIZATION; HUMANS; PHARMACY SERVICE, HOSPITAL; POLYPHARMACY; PROBLEM SOLVING;

EID: 76749121920     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02040.x     Document Type: Review

References (121)

1. Kennerfalk A, Ruigomez A, Wallander MA, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilisation in the United kingdom. Ann Pharmacother 2002 36 : 797 803.
2. Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP et al. The complexity and cost of drug regimens of older patients hospitalised with heart failure in the United States, 1998-2001. Arch Intern Med 2005 165 : 2069 2076. (Pubitemid 41434581)
3. Fried L, Walston J. Failure to thrive. In : Hazzard WH, Blass JP, Ettinger WH, Halter JB, Ouslander JG, eds. Principles of Geriatric Medicine and Gerontology, 4th 2 New York : McGraw Hill 1999 1387 1402.
4. Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP et al. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997 45 : 945 948.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998 279 : 1200 1205.
6. Hanlon JT, Schmader KE, Ruby CM, Weinberger M. Suboptimal prescribing in elderly inpatients and outpatients. J Am Geriatr Soc 2001 49 : 200 209.
7. Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G et al. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf 2008 31 : 545 556.
8. Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008 42 : 1017 1025.
9. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005 22 : 767 777.
10. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ et al. Adverse drug reactions as cause of admissions to hospital: Prospective analysis of 18 820 patients. BMJ 2004 329 : 15 9.
11. Beijer HJM, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002 24 : 46 54.
12. Hanlon JT, Pieper CF, Hajjar ER, Sloane RJ, Lindblad CI, Ruby CM et al. Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. Gerontol A Biol Sci Med Sci 2006 61 : 511 515.
13. Doucet J, Jego A, Noel D, Geffroy CE, Capet C, Coquard A et al. Preventable and non-preventable risk factors for adverse drug events related to hospital admissions in the elderly. A prospective study. Clin Drug Invest 2002 22 : 385 392.
14. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001 31 : 199 205.
15. Carbonin P, Pahor M, Bernabei R, Sgadari A. Is age an independent risk factor of adverse drug reactions in hospitalised medical patients? J Am Geriatr Soc 1991 39 : 1093 1099.
16. Van Kraaij DJW, Haagsma CJ, Go IH, Gribnau FW. Drug use and adverse drug reactions in 105 elderly patients admitted to a general medical ward. Neth J Med 1994 44 : 166 173.
17. Buajordet I, Ebbesen J, Erikssen J, Brors O, Hilberg T. Fatal adverse drug events: the paradox of drug treatment. J Intern Med 2001 250 : 327 341.
18. Bero LA, Lipton HL, Bird JA. Characterisation of geriatric drug-related hospital readmissions. Med Care 1991 29 : 989 1003.
19. Zhang M, Holman CDJ, Price SD, Sanfilippo FM, Preen DB, Bulsara MK. Comorbidity and repeat admission to hospital for adverse drug reactions in older adults: retrospective cohort study. BMJ 2009 338 : 155 158.
20. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. JAMA 2005 293 : 2131 2140.
21. Field TS, Gurwitz JH, Avom J, McCormick D, Jain S, Eckler M et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001 161 : 1629 1634.
22. Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003 15 (Suppl. 1 i49 59.
23. Green JL, Hawley JN, Rask KJ. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007 5 : 31 9.
24. McElnay JC, McCallion CR, Al-Deagi F, Scott MG. Development of risk model for adverse drug events in the elderly. Clin Drug Invest 1997 13 : 47 55.
25. Hilmer SN, Mager DE, Simonsick EM, Cao Y, Ling SM, Windham G et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007 167 : 781 787.
26. Goldberg RM, Mabee J, Chan L, Wong S. Drug-drug and drug-disease interactions in the emergency department: analysis of a high risk population. Am J Emerg Med 1996 14 : 447 450.
27. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Thera 2009 85 : 86 8.
28. Rochon PA, Gurwitz JH. Prescribing for seniors: neither too much nor too little. JAMA 1999 282 : 113 115.
29. Tinetti ME, Bogardus ST Jr., Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 351 : 2870 2874.
30. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. Implications for pay for performance. JAMA 2005 294 : 716 724.
31. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007 21 : 217 230.
32. Holmes HM, Hayley DC, Alexander GC, Sachs GA. Reconsidering medication appropriateness for patients late in life. Arch Intern Med 2006 166 : 605 609.
33. Ungar A, Pepe G, Lambertucci L, Fedeli A, Monami M, Mannucci E et al. Low diastolic ambulatory blood pressure is associated with greater all-cause mortality in older patients with hypertension. J Am Geriatr Soc 2009 57 : 291 296.
34. Gallagher PF, Barry PJ, Ryan C, Hartigan I, O'Mahony D. Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria. Age Ageing 2008 37 : 96 101.
35. Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003 33 : 323 328.
36. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S et al. GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004 328 : 1490 1494.
37. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older. A systematic review. Drugs Aging 2008 25 : 1021 1031.
38. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Isr Med Assoc J 2007 9 : 430 434.
39. Graves T, Hanlon JT, Schmader KE, Landsman PB, Samsa GP, Pieper CF et al. Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med 1997 157 : 2205 2210.
40. Froom J, Trilling J. Reducing antihypertensive medication use in nursing home patients. Arch Fam Med 2000 9 : 378 383.
41. Nelson MR, Reid CM, Krum H, Muir T, Ryan P, McNeil JJ. Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national drug pressure study cohort. BMJ 2002 325 : 815.
42. Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA 2006 296 : 2927 2938.
43. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol 2009 8 : 151 157.
44. Campbell AJ, Robertson AC, Gardner MM, Norton RN, Buchner DM. Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial. J Am Geriatr Soc 1999 47 : 850 853.
45. van der Velde N, Stricker BH, Pols HAP, van der Cammen TJM. Risks of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2006 63 : 232 237.
46. Williams ME, Pulliam CC, Hunter R, Johnson TM, Owens JE, Kincaid J et al. The short-term effect of interdisciplinary medication review on function and cost in ambulatory elderly people. J Am Geriatr Soc 2004 52 : 93 8.
47. Spinewine A, Swine C, Dhillon S, Franklin BD, Tulkens PM, Wilmotte L et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ 2005 331 : 935 939.
48. Tamblyn R, Huang A, Perreault R, Jacques A, Roy D, Hanley J et al. The medical office of the 21st century (MOXXI): effectiveness of computerised decision-making support in reducing inappropriate prescribing in primary care. CMAJ 2003 169 : 549 556.
49. Fuat A, Hungin AP, Murphy JJ. Barriers to accurate diagnosis and effective management of heart failure in primary care: qualitative study. BMJ 2003 326 : 196 200.
50. Frank C, Godwin M, Verma S, Kelly A, Birenbaum A, Seguin R et al. What drugs are our frail elderly patients taking? Do drugs they take fail or fail to take put them at increased risk of interactions and inappropriate medication use? Can Fam Physician 2001 47 : 1198 1204.
51. Bradley CP. Uncomfortable prescribing decisions: a critical incident study. BMJ 1992 304 : 294 296.
52. Havranek EP, Abrams F, Stevens E, Parker K. Determinants of mortality in elderly patients with heart failure. Arch Intern Med 1998 158 : 2024 2028.
53. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997 277 : 115 121. (Pubitemid 27030178)
54. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett EL. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995 155 : 277 281.
55. Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence-based practice guideline implementation. Arch Intern Med 2003 163 : 2165 2172.
56. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004 140 : 714 720.
57. Le Couteur DG, Kendig H. Pharmaco-epistemology for the prescribing geriatrician. Aust J Ageing 2008 27 : 3 7.
58. Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994 154 : 2195 2200.
59. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994 272 : 292 296.
60. Steinman MA, Landefeld CS, Rosenthal GE, Berthenthal D, Sen S, Kaboli PJ. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc 2006 54 : 1516 1523.
61. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007 370 : 173 184.
62. Gallagher P, Barry P, O'Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther 2007 32 : 113 121.
63. Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM et al. A summated score for the medication inappropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994 47 : 891 896.
64. Spinewine A, Dumont C, Mallet L, Swine C. Medication Appropriateness Index: reliability and recommendations for future use. J Am Geriatr Soc 2006 54 : 720 722.
65. Jeffrey S, Ruby C, Twersky J, Hanlon JT. Effect of an interdisciplinary team on suboptimal prescribing in a long-term care facility. Consult Pharm 1999 14 : 1386 1389.
66. Tropea J, Slee J, Holmes AC, Gorelik A, Brand CA. Use of antipsychotic medications for the management of delirium: an audit of current practice in the acute care setting. Int Psychogeriatr 2009 21 : 172 179.
67. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults. Results of a US consensus panel of experts. Arch Intern Med 2003 163 : 2716 2724.
68. Mcleod PJ, Huang AR, Tamblyn RM, Gayton DC. Defining inappropriate practices in prescribing for elderly people: a national consensus panel. CMAJ 1997 156 : 385 387.
69. Barry PJ, O'Keefe N, O'Connor KA, O'Mahony D. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalised patients. J Clin Pharm Ther 2006 31 : 617 626.
70. O'Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing 2008 37 : 138 141.
71. Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatrics Soc 2007 55 (Suppl. 2 S373 82.
72. Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D. STOPP (Screening Tool of Older Persons's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008 46 : 72 83.
73. Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus list. Eur J Clin Pharmacol 2007 63 : 725 731.
74. Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians. Development of a prescribing indicators tool. Drugs Aging 2008 25 : 777 793.
75. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005 293 : 1348 1358. (Pubitemid 40381487)
76. Pitkala KH, Strandberg TE, Tilvis RS. Inappropriate drug prescribing in home-dwelling elderly patients: a population based study. Arch Intern Med 2002 162 : 1707 1712.
77. Van der Hooft CS, Jong GW, Dieleman JP, Verhamme KM, Van der Cammen TJ, Striker BH et al. Inappropriate drug prescribing in older adults: the updated Beers criteria - a population based cohort study. Br J Clin Pharmacol 2005 60 : 2137 2144.
78. Batty GM, Grant RL, Aggarwal R, Lowe D, Potter JM, Pearson MG et al. Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients. Age Ageing 2003 32 : 292 298.
79. Jano E, Aparasu RR. Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother 2007 41 : 438 448.
80. Hanlon JT. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002 40 : 166 176.
81. Lau DT, Kasper JD, Potter DE, Lyles A, Bennett RG. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005 165 : 68 74.
82. Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005 22 : 69 82.
83. Fick DM, Waller JL, Maclean JR, van den Heuvel R, Tadlock JG, Gottlieb M et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilisation. J Manag Care Pharm 2001 7 : 407 413.
84. Laroche ML, Charmes JP, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007 63 : 177 186.
85. Hanlon JT, Fillenbaum GG, Gerda G, Kuchibhatla M, Artz MB, Boult C. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002 40 : 166 176.
86. Avorn J, Soumerai SB, Everitt DE, Beers MH, Sherman D, Salem-Schatz SR et al. A randomised trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992 327 : 168 173.
87. Pimlott NJ, Hux JE, Wilson LM, Kahan M, Li C, Rosser WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomised controlled trial. CMAJ 2003 168.
88. Rahme E, Choquette D, Beaulieu M, Bessette L, Joseph L, Toubouti Y et al. Impact of a general practitioner educational intervention on osteoarthritis treatment in an elderly population. Am J Med 2005 118 : 1262 1270.
89. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK. A randomised controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly patients with polypharmacy. Am J Med 1996 100 : 428 437.
90. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001 30 : 205 211.
91. Garcia RM. Five ways you can reduce inappropriate prescribing in the elderly: a systematic review. J Fam Pract 2006 55 : 305 312.
92. Roughead E, Pratt N, Gilbert A. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf 2007 16 : 797 803.
93. Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly. A controlled trial of physician feedback. J Am Geriatr Soc 1990 38 : 31 6.
94. Bates DW, Leape LL, Cullen DJ, Laird N, Petersen LA, Teich JM et al. Effect of computerised physician order entry and team intervention in prevention of serious medication errors. JAMA 1998 280 : 1311 1316.
95. Yourman L, Concato J, Agostini JV. Use of computer decision support interventions to improve medication prescribing in older adults: a systematic review. Am J Geriatr Pharmacother 2008 6 : 119 129.
96. Coleman EA, Grothaus LC, Sandhu N, Wagner EH. Chronic care clinics: a randomised controlled trial of a new model of primary care for frail older adults. J Am Geriatr Soc 1999 47 : 775 783.
97. Strandberg TE, Pitkala KH, Berglind S, Nieminen MS, Tilvis RS. Multifactorial intervention to prevent recurrent cardiovascular events in patients 75 years or older: the Drugs and Evidence-Based Medicine in the Elderly (DEBATE) study: a randomised, controlled trial. Am Heart J 2006 152 : 585 592.
98. Allard J, Hebert R, Rioux M, Asselin G, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001 164 : 1291 1296.
99. Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K et al. Improving medication use in newly admitted home healthcare patients: a randomised controlled trial. J Am Geriatr Soc 2002 50 : 1484 1491.
100. Muir AJ, Sanders LL, Wilkinson WE, Schmader K. Reducing medication regimen complexity. A controlled trial. J Gen Intern Med 2001 16 : 77 82.
101. Whittington J, Cohen H. OSF healthcare's journey in patient safety. Qual Manag Health Care 2004 13 : 53 9.
102. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007 5 : 345 351.
103. Schnipper JL, Kirwin JL, Cotugno MC, Wahlstorm SA, Brown BA, Tarvin E et al. Role of pharmacist counselling in preventing adverse drug events after hospitalisation. Arch Intern Med 2006 166 : 565 571.
104. McAlister FA, Stewart S, Ferrua S, McMurray JV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. J Am Coll Cardiol 2004 44 : 810 819.
105. Schmader KE, Hanlon JT, Pieper CF, Sloane R, Ruby CM, Twersky J et al. Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. Am J Med 2004 116 : 394 401.
106. Saltvedt I, Spigset O, Ruths S, Fayers P, Kaasa S, Slevtvold O. Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study. Eur J Clin Pharmacol 2005 61 : 921 928.
107. Spinewine A, Swine C, Dhillon S, Lambert P, Nachega JB, Wilmotte L et al. Effect of a collaborative approach on the quality of prescribing for geriatric inpatients: a randomized, controlled trial. J Am Geriatr Soc 2007 55 : 658 665.
108. Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA. Does the addition of a pharmacist transition co-ordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004 2 : 257 264.
109. Harris MF, Zwar NA. Care of patients with chronic disease: the challenge for general practice. Med J Aust 2007 187 : 04 107.
110. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust 2002 177 : 189 192.
111. Roughead EE, Gilbert AL, Primrose JG, Sansom LN. Drug-related hospital admissions: a review of Australian studies published 1988-1996. Med J Aust 1998 168 : 405 408.
112. Cooke R, Arachchi NJ, Jayathissa S, Bruce R. Value of second medication history in reducing medication errors in a secondary hospital. Proceedings of 8th World Congress of Clinical Pharmacology and Therapeutics. Brisbane, 2004.
113. Elliott RA, Woodward MC, Oborne CA. Quality of prescribing for elderly inpatients at nine hospitals in Victoria, Australia. J Pharm Pract Res 2003 33 : 101 105.
114. Elliott RA, Woodward MC, Oborne CA. Indicators of prescribing quality for elderly hospital inpatients. Aust J Hosp Pharm 2001 31 : 19 25.
115. Elliott RA, Woodward MC, Oborne CA. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing. Age Ageing 2002 31 : 391 396.
116. Robertson J, Treloar CJ, Sprogis A, Henry DA. The influence of specialists on prescribing by GPs. A qualitative study. Aust Fam Physician 2003 32 : 573 576.
117. de Vries CS, van Diepen NM, Tromp TF, de Jong-van den Berg LT. Auditing GPs' prescribing habits: cardiovascular prescribing frequently continues medication initiated by specialists. Eur J Clin Pharmacol 1996 50 : 349 352.
118. Thomas DC, Leipzig RM, Smith LG, Dunn K, Sullivan G, Callahan E. Improving geriatrics training in internal medicine residency programs: best practices and sustainable solutions. Ann Intern Med 2003 139 : 628 634.
119. Bibowski RM, Ripsin CM, Lorraine VL. Physician-patient congruence regarding medication regimens. J Am Geriatr Soc 2001 49 : 1353 1357.
120. Hamdy RC, Moore SW, Whalen K, Donnelly JP, Compton R, Testerman F et al. Reducing polypharmacy in extended care. South Med J 1995 88 : 534 538.
121. Wu JYF, Leung WYS, Chang S, Lee B, Zee B, Tong PCY et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006 333 : 522 527.